The solutions provided via the alliance will assist system administrators in understanding system weaknesses and creating strategies to increase operational efficiency for quality and patient safety.
“We are excited about this strategic relationship in order to deliver the value and convenience of HelioMetrics Rx Diversion Analytics through Visante’s extensive network of clients,” said Cherie Mitchell, President of HelioMetrics, according to the release.”The goal of the partnership is to help clients simplify the complexity of controlled substance diversion investigations.”
Opioid drug diversion in hospitals has become a critical healthcare issue as the nation continues to struggle with the worst drug overdose epidemic in U.S. history.
“The alarming rate of prescription opiate use and abuse in the U.S. affects all persons and is reflected inside the walls of the healthcare organization,” said Greg Burger, VP at Visante, according to a release. “Our consulting services identify and mitigate organizational risk areas. We are excited about working with HelioMetrics analytical technology to further improve how hospitals identify diversion activity and accelerate investigations.”
More articles on quality:
NIH offers scientific symposium on the future of nursing science
How Yelp reviews can supplement HCAHPS scores
VA hospitals stop reporting quality data to Hospital Compare: 4 things to know
